Related by context. All words. (Click for frequent words.) 80 Anti Tumor Activity 79 Preclinical Data 79 Prolongs Survival 79 Clinical Trial Results 79 Antitumor Activity 78 Survival Benefit 78 Improves Survival 78 Meets Primary Endpoint 78 Drug Candidate 77 Oral Fingolimod 77 Pooled Analysis 76 Phase 2b Clinical Trial 76 Study Evaluating 76 Anti Tumor 76 Combination Treatment 76 Investigational Agent 75 Nicotine Vaccine 75 Drug Combo 75 Statistically Significant 75 Resistant Hypertension 75 Patients Treated With 75 Lung Cancer Survival 75 Patient Enrollment 75 Drug Shows Promise 75 Male Contraceptive 75 Osteoporosis Drugs 75 Breast Cancer Recurrence 75 Lupus Drug 75 HCV Protease Inhibitor 75 Completes Patient Enrollment 75 Lung Cancer Drug 75 Present Preclinical Data 75 Therapy Improves 75 Novel Oral 75 Adjuvant Chemotherapy 75 Phase 2b Trial 75 See CLINICAL PHARMACOLOGY 75 Demonstrates Efficacy 75 Renal Cell Carcinoma 74 Lung Cancer Trial 74 Patients Receiving 74 Shows Promising 74 Previously Treated 74 Is Well Tolerated 74 Fungal Infections 74 Phase 2a Trial 74 Advanced Prostate Cancer 74 Treated Patients 74 Novel Antibiotic 74 Improved Survival 74 Critically Ill Patients 74 Breast Tumors 74 Presents Preclinical Data 74 Shows Promise Against 74 Epilepsy Drug 74 Combo Therapy 74 Demonstrates Potent 74 Improves Outcomes 74 Phase 2b Study 74 Fewer Side Effects 74 Artery Disease 74 Cholesterol Lowering Drug 74 Prostate Cancer Patients 74 Osteoporosis Drug 74 Well Tolerated 74 Advanced Melanoma 74 Rheumatoid Arthritis Drug 74 Investigational Drug 74 Arthritis Drug 74 Clinical Outcome 74 Gout Drug 74 Migraine Drug 74 Relapsing Multiple Sclerosis 74 Gene Variation 74 Novel Mechanism 74 Treatment Regimen 74 Phase III Trial 74 FDA Okays 74 AnaSpec Introduces 74 Adjuvant Treatment 74 Unfractionated Heparin 74 Hormone Refractory Prostate Cancer 74 Preclinical Study 74 Kinase Inhibitor 73 Severe Sepsis 73 Phase IIb Clinical Trial 73 Demonstrates Positive 73 Hsp# Inhibitor 73 FDA Approvals 73 Kidney Function 73 Myeloma Patients 73 Single Dose 73 Therapeutic Antibody 73 Disease Progression 73 Appears Safe 73 Aggressive Prostate Cancer 73 HER2 Positive 73 Phase III Clinical Trial 73 Blood Pressure Drug 73 Treatment Reduces 73 Treatment Naive Patients 73 Gene Variants 73 Dendritic Cells 73 Rheumatoid Arthritis Patients 73 Gene Variant 73 Enlarged Prostate 73 Metastatic Renal Cell Carcinoma 73 Pediatric Patients 73 Demonstrated Significant 73 Hypertensive Patients 73 Treatment Naïve 73 First Patient Treated 73 Recombinant Human 73 Novel Inhibitor 73 Breast Cancer Cells 73 FDA Clears 73 Advanced Colorectal Cancer 73 Phase 2a Clinical Trial 73 Pharmacyclics Announces 73 Vaccine Adjuvant 73 Randomized Double Blind 73 Multiple Myeloma Patients 73 Drug Fails 73 Significant Improvements 73 Phase IIb Trial 73 Long Term Efficacy 73 Postmenopausal Women 73 Immune Cells 73 Gene Mutation 73 Pharmacokinetic Study 72 Shows Efficacy 72 Antiplatelet Therapy 72 Prostate Cancer Vaccine 72 Chronic Hepatitis C 72 Hepatitis C Infection 72 FDA Accepts 72 Submits NDA 72 Schizophrenia Drug 72 Osteoporosis Treatment 72 Synthetic Peptide 72 Proves Effective 72 Tyrosine Kinase Inhibitor 72 Kidney Transplant Patients 72 JAK2 Inhibitor 72 Advanced Ovarian Cancer 72 Colorectal Cancer Patients 72 Completes Enrollment 72 Trial Evaluating 72 Tumor Growth 72 Genes Linked 72 Investigational Compound 72 NDA Submission 72 Beneficial Effects 72 Files IND 72 Patients Treated 72 Develop Novel 72 Immunomedics Announces 72 Investigational Treatment 72 First Patient Dosed 72 Postmenopausal Osteoporosis 72 Milestone Payment 72 Knee Osteoarthritis 72 Demonstrates Statistically Significant 72 Antiviral Drugs 72 Versus Placebo 72 Effectively Treats 72 Pivotal Phase 72 Mouse Model 72 Hematological Cancers 72 JAK Inhibitor 72 Less Invasive 72 Myelodysplastic Syndromes 72 Combination Therapy 72 Improve Survival 72 Significantly Improves 72 Inhaled Corticosteroids 72 Bone Metastases 72 Peginterferon Alfa 2a 72 Significantly Improved 72 Randomized Trials 72 Cholesterol Drug 72 Confirmatory Phase 72 Treatment Shows Promise 72 Brain Metastases 72 Anticancer Drug 72 Treatment Experienced 72 Lowers Risk 72 Gastric Cancer 72 HER2 Positive Breast Cancer 72 Plaque Psoriasis 72 Therapeutic Efficacy 72 Cardiovascular Disease Risk 72 Receives Orphan Drug Designation 72 Hormone Receptor Positive 72 Topical Treatment 72 Relapsed Refractory 72 Significant Improvement 72 Visceral Fat 71 Chemotherapy Improves 71 Cholesterol Drugs 71 Patients Undergoing 71 Drug Prevents 71 Complicated Skin 71 Cardiotoxicity 71 Neoadjuvant Chemotherapy 71 Dose Escalation 71 Reduces Pain 71 Significantly Reduces 71 Epilepsy Drugs 71 Protease Inhibitor 71 Prostate Cancer Progression 71 Nuvelo Announces 71 Heart Failure Patients 71 Prostate Tumors 71 Treating Chronic 71 Inflammatory Disease 71 Stem Cell Procedure 71 Demonstrates Significant 71 Slow Progression 71 Clinical Trial Data 71 First Patient Enrolled 71 Showed Significant 71 Oral Presentations 71 Dose Finding 71 Potent Antiviral Activity 71 Combination REOLYSIN R 71 Initiates Phase III 71 Drug Resistant 71 RNAi Therapeutics 71 Multicenter Trial 71 Vitro Activity 71 Polymerase Inhibitor 71 Orally Active 71 Inflammatory Markers 71 Low Dose 71 Immune Responses 71 Elderly Patients 71 Inhaled Insulin 71 Renal Cancer 71 Antiviral Activity 71 Novel Compound 71 Cholesterol Lowering 71 Transdermal Patch 71 Significantly Reduced 71 Anticancer Drugs 71 Infected Patients 71 Metastatic Melanoma 71 Chemotherapy Regimen 71 Monotherapy 71 FDA Approves Drug 71 Statin Therapy 71 Double Blind Placebo 71 Anti Inflammatory Drug 71 Therapeutic Potential 71 Patients Suffering 71 Receptor Agonist 71 Lung Tumors 71 Blood Thinner 71 Mg Usa 71 Genes Involved 71 Immunomodulatory 71 Viral Infections 71 Obese Patients 71 Newly Diagnosed 71 Hepatitis C Treatment 71 RNAi Therapeutic 71 Meta Analysis 71 Cognitive Problems 71 Antifungal 71 Lung Cancers 71 Long Term Outcomes 71 Lung Cancer Patients 71 Leukemia Cells 71 Taro Receives 71 Novel Therapeutic 71 Immune Cell 71 Brain Scans 71 Liver Tumors 71 Testosterone Patch 71 Phase 1b Clinical Trial 71 Paclitaxel Carboplatin 71 Beta Blocker 71 Autologous Stem Cell Transplantation 71 Insulin Glargine 71 Study Demonstrates 71 Sangamo BioSciences Announces 71 Heartburn Drugs 71 Previously Untreated 71 Recurrent Breast Cancer 71 Sustained Efficacy 71 Subgroup Analysis 71 Drug Coated Stents 71 Anti Clotting Drug 71 Circulating Tumor Cells 71 Non Inferiority 71 Monoclonal Antibody 71 Prove Effective 71 Gene Mutations 71 Tezampanel 71 Predict Prostate Cancer 71 Study Showed 71 Erectile Dysfunction Drug 71 Bone Marrow Cells 70 Metastatic Prostate Cancer 70 Chemotherapeutic Agents 70 Long Term Survival 70 Diabetic Nephropathy 70 Cocaine Addiction 70 Initiate Phase III 70 Prognostic Value 70 Study Shows Benefits 70 Therapy Reduces 70 Stem Cell Transplants 70 Clinical Efficacy 70 Gene Linked 70 Prostate Cancer Treatment 70 Laryngeal Cancer 70 Viral Suppression 70 Newly Diagnosed Multiple Myeloma 70 Blood Clot Risk 70 Lymph Node 70 Topline Results 70 Mouse Models 70 Randomized Clinical Trials 70 Fracture Risk 70 Desvenlafaxine Succinate 70 Predict Risk 70 Pharmacokinetics PK 70 Antipsychotic Drug 70 Phase IIa Clinical Trial 70 Peginterferon 70 Localized Prostate Cancer 70 Increased Mortality 70 Medoxomil 70 Vaginal Gel 70 Dose Ranging 70 Premenopausal Women 70 Small Molecule 70 Mylan Receives Approval 70 Psoriasis Drug 70 IND Filing 70 Cancer Cells 70 Atypical Antipsychotics 70 Anticoagulant 70 Clinical Trial Evaluating 70 Relapsed Multiple Myeloma 70 Cancer Recurrence 70 Significant Reduction 70 Experimental Vaccine 70 Initiates Clinical Trial 70 Inflammatory Diseases 70 Randomized Phase 70 Demonstrates Sustained 70 Liver Toxicity 70 Kinase Inhibitors 70 Cardiac Function 70 Potentially Fatal 70 Adjuvant Therapy 70 Phospholipase A2 70 Minimally Invasive Treatment 70 Inflammatory Arthritis 70 IND Application 70 Migraine Treatment 70 Endothelial Cells 70 Breast Cancer Stem Cells 70 Malignant Glioma 70 Diabetic Foot Ulcer 70 Presents Positive 70 Transplant Patients 70 Levels Linked 70 Glufosfamide 70 Therapy Shows Promise 70 Vaccine Protects Against 70 Organ Rejection 70 Crit Rev 70 Blood Pressure Lowering 70 Anemia Drug 70 Antidepressants Linked 70 Epidermal Growth Factor Receptor 70 Controlled Study 70 Imaging Techniques 70 Pulmonary Arterial Hypertension 70 Breast Cancers 70 Sirolimus Eluting 70 Colon Polyps 70 Human Monoclonal Antibody 70 Randomized Double blind 70 II Clinical Trial 70 Menopausal Women 70 AVI BioPharma Announces 70 Sex Hormones 70 Osteoarthritis Pain 70 Molecular Mechanism 70 Novel Method 70 Synta Announces 69 Oral Cladribine 69 Sleep Disturbances 69 Slows Progression 69 Allergic Reactions 69 Pneumococcal Vaccine 69 Antitumor 69 Anti Nausea 69 Symptom Relief 69 Protein Linked 69 Breast Ultrasound 69 Study Evaluates 69 Cardiovascular Outcomes 69 Oral Anticoagulant 69 Carboplatin Paclitaxel 69 Initiate Clinical Trial 69 Protein Synthesis 69 Statin Drugs 69 Preclinical Models 69 Stomach Cancer 69 Hip Fractures 69 Chronic Hepatitis B 69 Placebo Controlled Study 69 Estrogen Therapy 69 Novel Compounds 69 PRN FDA Approves 69 Randomized Study 69 Fibromyalgia Pain 69 Successfully Completes Phase 69 Uric Acid 69 Genes Predict 69 Skeletal Muscle 69 Acne Drug 69 Interferon Beta 69 Initiate Phase 69 Secondary Hyperparathyroidism 69 Randomized Clinical Trial 69 R lenalidomide 69 Ebola Vaccine 69 Late Breaker 69 Lowers Blood Pressure 69 Insulin Pen 69 Vaccine Candidate 69 Rotavirus Vaccine 69 Cerebrospinal Fluid 69 Attenuates 69 Melphalan 69 Pre Cancerous 69 Breast Cancer Metastasis 69 Respiratory Distress 69 Stem Cell Treatment 69 Genetic Variant 69 Zoledronic Acid 69 Aurora Kinase 69 Endovascular Treatment 69 Blood Clotting 69 Mimetics 69 Transdermal Delivery 69 Androgen Deprivation Therapy 69 Anti Angiogenic 69 Bare Metal Stents 69 Smooth Muscle 69 Vaccine Prevents 69 Chronic Cough 69 Guidelines Issued 69 Nat Clin Pract 69 Prognostic Significance 69 Plus Ribavirin 69 Cancer Treatments 69 Diabetic Neuropathy 69 Inhaled Nitric Oxide 69 Proven Effective 69 Reduced Risk 69 Blood Cancers 69 Teva Provides Update 69 Lowering Blood Pressure 69 Tolerability 69 Kidney Transplant Recipients 69 Colorectal Adenomas 69 Ovarian Cancers 69 Epoetin Alfa 69 Calcium Supplements 69 Reduces Risk 69 Pregnancy Complication 69 Asthma Treatment 69 Unresectable 69 Breast Cancer Tumors 69 Test Detects 69 Diuretic 69 Generic Version 69 Regenerative Cells 69 Renal Cell Cancer 69 Prospective Randomized 69 NMDA Receptor 69 Genetic Mutation 69 Shown Effective 69 Poster Presentations 69 Shingles Vaccine 69 Novel Peptide 69 Refractory Hodgkin Lymphoma 69 Castration Resistant Prostate Cancer 69 Anthrax Toxin 69 Spectrum Pharmaceuticals Announces 69 Chronic Stress 69 Pivotal Study 69 MEK Inhibitor 69 Receives Approvable Letter 69 Cardiovascular Events 69 Bone Marrow Stem Cells 69 Autoimmune Disorders 69 Radiation Induced 69 Thyroid Hormone 69 Platelet Inhibition 69 Dose Ranging Study 69 Migraine Headaches 69 Septic Shock 69 Parathyroid Hormone 69 Granted Orphan Drug 69 Sirolimus Eluting Stent 69 Genetic Variation 69 Recurrent Ovarian Cancer 69 Data Suggest 69 Generic Versions 69 Drug Eluting 69 Recombinant Protein 69 Breast Cancer Treatment 69 Treat Heart Failure 69 Clot Risk 69 Lung Cancer Diagnosis 69 Cancer Stem Cells 69 Colorectal Cancer Risk 69 Hepatic Encephalopathy 69 Patients Enrolled 69 Acute Ischemic Stroke 69 Antibiotic Treatment 69 Anthracycline 69 Malignant Melanoma 69 Avian Flu Vaccine 69 Prophylactic Treatment 69 Naive Patients 69 Skin Lesions 69 Detect Cancer 69 Tumor Targeting 69 Protein Involved 69 Angiogenic 69 Brentuximab Vedotin SGN 69 Calcium Vitamin D 69 Breast Density 69 Preterm Delivery 69 Peginterferon Alfa 2b 69 Adjunctive Therapy 69 Helps Identify 69 Liver Metastases 69 Fixed Dose 69 Muscle Wasting 69 Disease Modifying 69 Genes Associated 69 Peanut Allergies 69 Phase Ib Clinical Trial 69 Double Blind Randomized 69 Moderate Drinking 69 Initiates Enrollment 69 Virus Infection 69 Hedgehog Pathway 69 Cell Transplants 69 Prostate Cancer Survival 69 Endometrial Cancer 69 Viral Load 68 Lung Infections 68 Cervical Dysplasia 68 Weight Loss Drug 68 Schiavo Autopsy 68 Diagnostic Tools 68 ORLive Presents 68 Insulin Sensitivity 68 Diabetic Patients 68 Venous Thromboembolism 68 Enhanced Version 68 Obesity Linked 68 Autoimmune Disease 68 Obese Teens 68 Key Milestones 68 Genetic Defect 68 Insulin Resistance 68 Genetic Variants 68 Novel Anti Inflammatory 68 Novel Treatments 68 Biologic Therapy 68 Initiates Clinical Trials 68 Glycemic Control 68 Liver Failure 68 Enzo Biochem Reports 68 Magnetic Stimulation 68 Preterm Labor 68 Hormonal Therapy 68 Companion Diagnostic 68 Stent Thrombosis 68 Dosage Forms 68 Osteoarthritis Patients 68 Genetic Variations 68 Successfully Treated 68 Treating Depression 68 Protease Inhibitors 68 Sustained Release 68 Acne Scars 68 Earns Milestone Payment 68 Nymox NX 68 TB Vaccine 68 Inhibits 68 Predict Breast Cancer 68 Intravenous Formulation 68 Demonstrate Significant 68 Chronic Sinusitis 68 J Clin 68 Pivotal Trials 68 Often Misdiagnosed 68 Breast Cancer Patients 68 Pivotal Phase III 68 Newly Diagnosed Patients 68 Effective Treatments 68 Dose Response 68 Phase III Trials 68 Cholesterol Levels 68 Heart Stents 68 Molecular Diagnostic Test 68 Sinus Infections 68 Brain Atrophy 68 Tipranavir 68 Blood Pressure Drugs 68 Could Predict 68 Sustained Reduction 68 Cervical Cancer Vaccine 68 Renal Anemia 68 Gum Disease 68 Soft Tissue Sarcoma 68 Painkiller Abuse 68 Liver Injury 68 Signaling Pathways 68 Tremendous Growth 68 Ovarian Cancer Patients 68 Diabetic Kidney Disease 68 Overactive Bladder 68 Urinary Incontinence 68 Ischemic Stroke 68 Capsules CII 68 Immunogenicity 68 Contrast Agents 68 XPEL Announces 68 HDAC Inhibitor 68 Study Casts Doubt 68 Strongly Linked 68 Collaborators Present 68 Patient Accrual 68 Reports Preclinical Data 68 Effective Than 68 Resistant Bacteria 68 ACE Inhibitors 68 Efficacy Trial 68 Vaccine Adjuvants 68 Node Positive 68 Coronary Artery Calcium 68 Severe Acne 68 Menopausal Symptoms 68 Treatment Resistant 68 Medullary Thyroid Cancer 68 Systemic Delivery 68 Oral Calcitonin 68 Artificial Pancreas 68 Improves Accuracy 68 Helps Predict 68 Antibody Drug Conjugate 68 Non Invasive Treatment 68 Certain Cancers 68 Lower Blood Pressure 68 Treatment Naive 68 Antiviral Therapy 68 Sapacitabine 68 Carotid Stenting 68 Prostate Biopsy 68 Bosutinib 68 Genetic Mutations 68 Smallpox Vaccine 68 Thrombotic 68 Tumor Cells 68 Preclinical Efficacy 68 Randomized Controlled Trials 68 Schizophrenia Treatment 68 Bipolar Depression 68 Therapeutic Vaccine 68 Inflammatory Response 68 Cardiovasc 68 Anticancer Agent 68 Novel Vaccine 68 Newly Identified 68 Modulates 68 Histone Deacetylase 68 DNA Methylation 68 Prostate Cancer Recurrence 68 Lipid Lowering 68 Demonstrates Potential 68 Seasonal Allergies 68 Clinical Study Shows 68 Oral Formulation 68 Kidney Tumors 68 Hemodialysis Patients 68 Factor Receptor 68 Hepatitis C Virus 68 Abdominal Fat 68 Largest Database 68 Fecal Incontinence 68 Stent Implantation 68 Capecitabine 68 Endovascular Repair 68 Invasive Breast Cancer 68 J Shoulder Elbow 68 Int J Obes Relat 68 Oral Spray 68 Bone Marrow Transplants 68 Genetic Tests 68 Expanded Indication 68 Guidelines Recommend 68 Anti CD# Antibody 67 Weight Loss Supplement 67 Oral Cavity 67 Boosts Survival 67 Tissue Engineered 67 Venous Thrombosis 67 Emerging Therapies 67 Antibiotic Use 67 Ovarian Cancer Risk 67 Prolongs Life 67 FDA Panel Recommends 67 Innate Immune 67 Myocardial Perfusion Imaging 67 Proves Successful 67 Antidepressant Use 67 Virus Linked 67 ST Elevation Myocardial 67 Blood Thinning 67 Shows Promise 67 Efficacious 67 Menstrual Pain 67 Fondaparinux 67 Fulvestrant 67 Drug Resistant HIV 67 Antiplatelet 67 Fluorouracil 67 Viral Infection 67 Renal Function 67 Ovary Removal 67 Intracranial Aneurysms 67 Hospitalization Rates 67 Ovarian Cancer Treatment 67 Helps Smokers Quit 67 Oncolytic 67 Ultrasensitive 67 Imaging Technique 67 Left Ventricular Hypertrophy 67 Hematological Malignancies 67 Malaria Vaccine 67 Bacterial Infection 67 OxyContin Maker 67 Controlled Trial 67 Endothelial Function 67 Novel Protein 67 Diagnostic Tests 67 Drug Resistant Staph 67 Antidepressant Drug 67 Atopic Dermatitis 67 Phase III Pivotal 67 美 通 社 67 Initiates Phase II 67 Relapsing Remitting Multiple Sclerosis 67 Initiates Phase 67 Therapeutic Vaccines 67 Stent Placement 67 Receives Orphan Drug 67 Study Shows Promise 67 Primary Endpoint 67 Acute Heart Failure 67 Contrast Agent 67 Antipsychotic Drugs 67 Endothelial Dysfunction 67 Hepatitis C Genotype 67 Pivotal Trial 67 BiTE Antibody 67 Genital Warts 67 Telik Announces 67 Antisense Drug 67 Randomized Phase II 67 Vertebral Fractures 67 Contrast Enhanced 67 Vitamin D Linked 67 Tablet Formulation 67 Diabetic Foot Ulcers 67 Glucose Metabolism 67 Arch Facial Plast 67 Placebo Controlled Trial 67 Renal Tumors 67 Statistical Significance 67 Prognostic Factors 67 Shows Statistically Significant 67 Excessive Sweating 67 Initiates Phase 2b 67 Signaling Pathway 67 Lipid Levels 67 Newly Diagnosed Breast Cancer 67 Beta Blockers 67 Prostate Cancers 67 Antigen Specific 67 Device Helps 67 Allogeneic 67 Tumor Necrosis Factor 67 Neural Stem Cells 67 Trial Halted 67 Muscle Function 67 Severe Asthma 67 Novel Therapies 67 Aspirin Therapy 67 Announces FDA Clearance 67 Treatment Naive HIV 67 Drug Regimen 67 Chronic Inflammation 67 Cyclooxygenase 2 67 Files Investigational 67 Cancer Therapies 67 Commonly Used 67 Metastatic Colorectal Cancer 67 Magnetic Nanoparticles 67 Anti Inflammatory 67 Tumor Cell 67 Smoking Linked 67 Prostate Cancer Detection 67 Induces 67 Kidney Transplants 67 Relapsed Refractory Aggressive 67 Irvine Sensors Receives 67 Hormone Therapy 67 Aliskiren 67 Chronic Lymphocytic Leukemia 67 Cardiac Troponin 67 Clinically Significant 67 ST Segment Elevation 67 Bioartificial Liver 67 Nanoemulsion 67 Migraine Pain 67 Safinamide 67 Acute Migraine 67 FOR WELL BEING 67 Brain Cells 67 Breast Tumor 67 Clin Oncol 67 Testosterone Gel 67 Cinacalcet 67 Aeolus Pharmaceuticals Announces 67 Cardiac Resynchronization 67 Inherited Diseases 67 Drug Combinations 67 Partial Onset Seizures 67 Tumor Response 67 Novel Antibody 67 Safety Tolerability 67 Asthma Symptoms 67 Neoadjuvant 67 Cold Sores 67 Remission Maintenance 67 Hepatocellular 67 Biomarker Study 67 Hypercholesterolemia 67 Progenitor Cells 67 Antipsychotic 67 Benign Prostatic Hyperplasia 67 Exercise Reduces 67 Seamless Integration 67 ADHD Medication 67 Pain Relievers 67 Receives Milestone Payment 67 Eur J 67 Brain Tumor Patients 67 Metastatic Pancreatic Cancer 67 Bloodstream Infections 67 Initiates Clinical 67 Improves Quality 67 Childhood Trauma 67 Clinical Trial Enrollment 67 Breast Exams 67 Metabolic Disorder 67 Study Shows Significant 67 FDA Clearance 67 Interferon Alpha 67 Chemoradiation 67 Refractory Angina 67 Potentially Deadly 67 Psychopharmacol 67 Gets FDA Clearance 67 Diet Pill 67 Nucleoside 66 Clinical Evaluation 66 Potent Anti 66 VIVUS Announces 66 Hospital Acquired Pneumonia 66 Blood Stem Cells 66 Blood Clots 66 Dose Escalation Study 66 Receives FDA Clearance 66 Improve Outcomes 66 Total Knee Arthroplasty 66 Telaprevir VX 66 Inhaled Steroids 66 Mitral Valve Repair 66 Blood Vessels 66 Pegylated Interferon 66 Equity Funds Declare 66 Clinically Proven 66 Protein Structures 66 Treatment Naïve Patients 66 Left Ventricular 66 Prostate Screening 66 Vaccine Shows Promise 66 Clostridium difficile Infection 66 CYP#A# CYP#D# 66 PDUFA Date 66 Lung Cancer Treatment 66 TO AVOID PREGNANCY WHILE 66 Dementia Patients 66 Induction Therapy 66 Chronic Myeloid Leukemia 66 Radical Prostatectomy 66 Depressive Symptoms 66 Lung Cancer Risk 66 Embolization 66 Genes Identified 66 Antiangiogenic 66 CCX# B 66 J Allergy Clin 66 Disease Modification 66 5 Fluorouracil 66 Bone Fractures 66 Peripheral Blood 66 Advanced Renal Cell 66 Adenoma 66 Study Reinforces 66 Bare Metal Stent 66 Provides Detailed 66 Physical Function 66 Clinically Tested 66 Osteoarthritis Knee Pain 66 Gastrointestinal Stromal Tumors 66 Synaptic Plasticity 66 Randomized Phase III 66 Bacterial Infections 66 Chronic Constipation 66 Radiation Dose 66 Serious Infections 66 RNA Interference 66 Radiofrequency Ablation 66 TRANSDUR ™ 66 Genetic Markers 66 Findings Reveal 66 Medicure Announces 66 GeoMet Announces 66 Rat Poison Found 66 Maven Semantic 66 Contains Detailed 66 Gene Silencing 66 Oral Mucositis 66 Surgical Procedures 66 Psoriasis Patients 66 Lung Infection 66 Targeted Therapies 66 Hepatitis B Vaccine 66 siRNA Delivery 66 PPD Declares 66 Glaucoma Treatment 66 Immunosuppression 66 Anticancer Compound 66 Significantly Enhances 66 Phase III Clinical Trials 66 Placebo Controlled 66 Colorectal Cancers 66 Low Density Lipoprotein Cholesterol 66 Presents Preclinical 66 Mg Uk 66 Impairs 66 Cell Adhesion 66 Breast Tissue 66 Tigecycline 66 Merge Healthcare Announces 66 Drug Eluting Coronary Stent 66 Tiotropium 66 Treat Anemia 66 Bevacizumab 66 Pioglitazone 66 Liver Damage 66 Extended Release Formulation 66 Confirms Efficacy 66 Diamyd Medical Diamyd 66 Immunotherapeutic 66 Diagnostic Criteria 66 Submits Biologics License Application 66 Predict Response 66 NPS Pharmaceuticals Announces 66 FDA Warns Against 66 Heart Failure Therapy 66 Skin Cells